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Editorial on the Research Topic
Langerhans Cells and How Skin Pathology Reshapes the Local Immune Environment
The skin is an important barrier site. It contains a dynamic network of immune cells that
ensure tolerance to daily insults, whilst maintaining the capacity to rapidly initiate innate and
adaptive immune responses to more threatening challenges. In the steady state, the biology of the
development and function of most skin immune cells has been well-defined. However, immune
pathology, driven by infection or autoimmune triggers, may extensively damage both the local
architecture, and alter the immune cell compartment. Little is known about how these acute
changes reshape the tissue environment or immune homeostasis once pathology has resolved. One
example is cutaneous graft-vs.-host disease (GVHD) that occurs when donor T cells attack healthy
skin cells after allogeneic hematopoietic stem cell transplant (allo-HSCT). Here, T cell pathology
not only dramatically alters the local inflammatory environment, but destruction of resident cells by
cytotoxic T cells may lead to re-organization of the immune cell network. However, the long-term
consequences of these changes for immune function in the skin are unknown.
Langerhans cells (LC) are antigen presenting cells which are unique to the skin epidermis,
although similar cells may be found at other epithelial sites, such as the oral mucosa. LC were first
identified by Paul Langerhans in the nineteenth Century, due to their striking dendriticmorphology
in the skin epidermis, but it took another 100 years before their importance in skin immunity began
to be appreciated by early pioneers in the field [for a comprehensive review see (1)]. More recently,
shifts in our understanding of the developmental biology of LC have lead researchers to describe
new functions for LC in the skin and draining lymph nodes (LN).
This research topic brings together six articles that provide both insight into our current
understanding of LC and in health and disease, and new perspectives in our view of LC function.
Further, we have included a seventh article, by Li et al. in the format of a methods paper, presented
to quantify andmeasure some of the skin’s immunological responses. The field is heavily dependent
on assays, such as caliper-based measurements of wound size, tumor growth, and ear swelling that
are subject to user variability, and here we present novel, unbiased approaches for quantification.
Deckers et al. present our current understanding of the ontogeny and function of LC, and
their involvement in skin disease, with a focus on allergy and autoimmunity. Following this, a
series of reviews present novel concepts in current thinking on how LC function, and are wired.
Sagi and Heironymus explore the concept that migration of LC out of the skin to LN requires
activation of an epithelial to mesenchymal transition (EMT), which is more commonly associated
with the acquisition of metastatic and migratory potential of carcinomas. They discuss current
knowledge of Met/HBFG signaling in LC and dendritic cells (DC), and propose the importance
of this signaling pathway for LC mobilzation and therefore function. This is complimented by the
mini-review by West and Bennett who explore the concept that our historical focus on LC as cells
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that pre-dominantly migrate to LN to prime T cell immunity,
may have masked our appreciation of other roles directly in the
skin. They argue that LC function in situ within the epidermis
is consistent with their embryonic origin as tissue macrophages.
Finally, Clayton et al. have utilized novel transcriptomics
approaches to define gene regulatory networks in human LC,
and assess how these may provide clues to LC development and
function. This work highlights the uniqueness of epidermal LC
compared to macrophages and DC.
In two subsequent reviews, we focus on the role of LC in
clinical disease. In their mini-review, Santos e Sousa et al. discuss
the pathology associated with clinical graft-vs.-host disease
(GVHD), and how this alters the skin immune environment.
LC are radio-resistant, and persist as the major allogeneic
professional antigen presenting cell population in the skin of
patients after allo-HSCT. This, with the assumption of their
dominant role in priming T cell immunity, led to the long-held
view that they were responsible for cutaneous GVHD. However,
recent work has challenged this view, and the role of LC in
GVHD pathology remains controversial. Santos e Sousa et al.
present their novel finding that epidermal LC drive GVHD by
directly regulating T cell function in the skin. In comparison,
Eidsmo and Martini discuss the direct role of LC for on-
going pathology during psoriasis. Disease is characterized by the
recurrence of lesions at fixed sites. Here, they discuss evidence
that LC may maintain a transcriptional “memory” of pathology,
perhaps providing a biological explanation for the localization of
the pathological response.
Fundamentally, this research topic represents our growing
understand of the varied roles LCs play and how they contribute
to skin immunity in the steady state and in disease.
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